Tag: Federal Circuit Court

The Federal Circuit Court holds exclusive authority over U.S. pharmaceutical patent cases, shaping how generics enter the market, how patents are challenged, and how long drugs stay expensive. Its rulings on ANDA filings, Orange Book listings, and dosing patents directly impact drug access and innovation.